Integra LifeSciences Holdings Corporation (IART)
- Previous Close
17.57 - Open
17.60 - Bid 17.62 x 100
- Ask 17.72 x 100
- Day's Range
17.57 - 18.07 - 52 Week Range
17.56 - 45.42 - Volume
592,621 - Avg. Volume
1,525,225 - Market Cap (intraday)
1.369B - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
60.86 - EPS (TTM)
0.29 - Earnings Date Oct 23, 2024 - Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
28.00
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
www.integralife.comRecent News: IART
View MorePerformance Overview: IART
Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IART
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IART
View MoreValuation Measures
Market Cap
1.36B
Enterprise Value
3.08B
Trailing P/E
60.62
Forward P/E
7.09
PEG Ratio (5yr expected)
0.59
Price/Sales (ttm)
0.88
Price/Book (mrq)
0.89
Enterprise Value/Revenue
1.96
Enterprise Value/EBITDA
14.31
Financial Highlights
Profitability and Income Statement
Profit Margin
1.51%
Return on Assets (ttm)
3.51%
Return on Equity (ttm)
1.47%
Revenue (ttm)
1.57B
Net Income Avi to Common (ttm)
23.65M
Diluted EPS (ttm)
0.29
Balance Sheet and Cash Flow
Total Cash (mrq)
296.93M
Total Debt/Equity (mrq)
131.10%
Levered Free Cash Flow (ttm)
112.64M